Featured Article

Prostate cancer is a common form of cancer that affects men, especially those over the age of 50. It is estimated that approximately 191,930 new cases of prostate cancer will be diagnosed in the United States in 2020, making it the second most commonly diagnosed cancer in men after skin cancer [1]. While there are various treatment options available for prostate cancer, hormone treatment has been gaining attention for its positive benefits in managing this disease.

Hormone treatment for prostate cancer, also known as androgen deprivation therapy (ADT), works by blocking the production or action of male hormones, specifically testosterone. This is because testosterone stimulates the growth and spread of prostate cancer cells. By depriving the body of testosterone, hormone treatment can slow down or stop the growth of cancer cells, and in some cases, even shrink them.

One of the main benefits of hormone treatment is that it is a non-invasive form of treatment. Unlike surgery or radiation therapy, hormone treatment does not require any surgical incisions or exposure to radiation, making it a preferred option for many patients. This also means that there is no risk of complications from surgery, such as bleeding or infection, or side effects from radiation therapy, such as fatigue or skin irritation.

In addition to being non-invasive, hormone treatment has also been found to be effective in controlling the progression of prostate cancer. In fact, research has shown that hormone treatment can slow down the growth of prostate cancer for years, and in some cases, even for the rest of a patient's life [2]. This can greatly improve the quality of life for patients, as they do not have to constantly worry about the cancer spreading or relapsing.

Hormone treatment has also been found to be beneficial for patients who have advanced or metastatic prostate cancer. In these cases, the cancer has spread beyond the prostate to other parts of the body. Hormone treatment can help shrink tumors in these areas and slow down the spread of cancer, providing patients with a better chance of survival and a higher quality of life.

Furthermore, hormone treatment has been found to be effective in managing some of the unpleasant symptoms associated with prostate cancer. For instance, prostate cancer can cause urinary problems, such as difficulty in urination or frequent urination. Hormone treatment can help shrink the prostate gland, which can alleviate these symptoms. In addition, studies have shown that hormone treatment can also improve bone density, reduce the risk of bone fractures, and decrease the likelihood of cancer-related pain [3].

Aside from managing prostate cancer, there is evidence that hormone treatment may also have a positive impact on overall health. Some studies have shown that hormone treatment may lower the risk of heart attacks and other cardiovascular issues [4]. This could be due to the fact that testosterone plays a role in maintaining a healthy cardiovascular system.

Despite the numerous positive benefits of hormone treatment for prostate cancer, it is important to note that it is not suitable for all patients. Hormone treatment may not be recommended for patients with certain medical conditions, such as heart disease or a history of strokes. It is important for patients to consult with their doctor to determine the best treatment option for their specific case.

In conclusion, hormone treatment for prostate cancer has many positive benefits that make it a valuable option for patients. It is non-invasive, effective in controlling the progression of cancer, and can improve the quality of life for patients. It is important for patients to have open and honest discussions with their healthcare team to determine if hormone treatment is the right choice for them. With ongoing research and advancements in technology, hormone treatment continues to offer hope for a better quality of life for those diagnosed with prostate cancer.

References:

1. American Cancer Society. (2020). Cancer Facts and Figures 2020. Retrieved from https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf

2. Prostate Cancer Foundation. (n.d.). Hormone Therapy for Prostate Cancer: What You Need to Know. Retrieved from https://www.pcf.org/c/hormone-therapy-prostate-cancer-need-know/

3. American Cancer Society. (2020). Hormone Therapy for Prostate Cancer. Retrieved from https://www.cancer.org/cancer/prostate-cancer/treating/hormone-therapy.html

4. Denham, J. W., Steigler, A., Lamb, D. S., Joseph, D., Mameghan, H., Turner, S., . . . Matthews, J. (2011). Short- and Medium-Term Outcomes of Dose-Escalated External Beam Radiation Therapy for Localized Prostate Cancer: Results of the Trans-Tasman Radiation Oncology Group 96-01 Randomised Controlled Trial. The Lancet Oncology, 12(5), 451-60. doi